17th Annual Sleep Medicine

Virtual CME Course

Saturday, March 22, 2025

Alon Y. Avidan, MD, MPH , Course Director

Overview

Clinicians in all areas of medicine encounter patients who complain of disturbed sleep. Taught by prominent sleep educators in the country, this all-day virtual sleep medicine review is designed to strengthen clinicians’ proficiency in recognizing, diagnosing, and managing sleep disorders longitudinally, from infancy to old age.

Registration

Saturday, March 22, 2025.
TIME: Official Start Time: 7:45 AM PST
Registration opens at 7:00 AM PST

For a PDF of the Webinar ZOOM Instructions, please click HERE

Webinar ZOOM Link

The course will be streamed via ZOOM starting at 7:45 AM PST

Please click here:

https://uclahs.fyi/Sleep2025

Slide Syllabus

Introduction

Physicians in all areas of medicine encounter patients who complain of disturbed sleep. The purpose of this course, the 17th in its series, is to provide clinicians with the knowledge needed to recognize and treat major sleep disorders likely to be encountered in their clinical practice.
The course would emphasize a practical approach to sleep medicine across multiple specialties, including primary care medicine, family practice, psychiatry, neurology, geriatrics, and clinical psychology.
The course will focus on the assessment and evaluation of excessive sleepiness, sleep apnea, and narcolepsy, appreciate evaluation strategies and management of chronic insomnia and circadian disorders, and be able to recognize critical parasomnias and abnormal behaviors at night.
The course will conclude with a discussion of the mechanism by which how poor sleep contributes to cognitive decline and dementia.
Attendees will acquire skills needed in the recognition, evaluation, and management of the major sleep disorders they are likely to encounter during routine clinical practice. A primary goal of the course is to provide practitioners with both pragmatic evaluation strategies and treatment recommendations that may be integrated into their clinical practice.
Course faculty will discuss etiology, pathophysiology, diagnostic strategies, and pharmacological and behavioral treatment options and harmonize the management strategies based on evidence-based medicine and shared decision-making.

Target Audience

This course targets clinicians and healthcare providers who regularly encounter patients with sleep complaints. The course will be of value to primary care physicians, internists, family physicians, psychiatrists, neurologists, psychologists, pediatricians, geriatricians, obstetricians and gynecologists, physician assistants, nurse practitioners, and any other healthcare providers who are likely to encounter patients with sleep disturbances.
Trainees in the primary care disciplines, family medicine, neurology, psychiatry, and sleep medicine would also find the course helpful.

Course Objectives

Appreciate the function of sleep, particularly relating to glymphatic clearance at night and comprehend the underlying physiologic basis giving rise to sleep and wakefulness.
Appreciate the causes of sleepiness in specific patient populations most likely encountered in primary care practice and by specialists in family medicine, primary care, psychiatry, neurology, pediatrics, and geriatrics medicine.
Identify the unique mechanism of narcolepsy and identify diagnostic approaches for accurate evaluation.
Appraise the current management strategies for central disorders of hypersomnia (narcolepsy and idiopathic hypersomnia) utilizing oxybates, Histamine 3 Inverse agonist, dopamine, and norepinephrine reuptake inhibitors and review the potential use of orexin agonists in narcolepsy.

Outline the clinical evaluation of sleep-disordered breathing, particularly physical exam findings and new diagnostic approaches based on emerging data on home monitoring equipment and wearable devices.
Review conservative management techniques to address obstructive sleep apnea, including the use of surgical interventions, upper airway stimulation, and newly approved glucagon-like peptide-1 receptor agonist in the setting of obesity and moderate to severe obstructive sleep apneas.
Discuss the utility of dual orexin receptor antagonists in managing insomnia
Recognize the critical importance contributes to cognitive decline and might also increase the risk of Alzheimer's disease dementia by promoting β-amyloid burden.
Investigate the causes of sleep disturbances in patients with neurodegenerative disorders.

17th Annual Sleep Medicine Virtual CME Course Faculty

Course Director

Sleep Function: Why We Sleep

Chronic Insomnia and Circadian Rhythm Disorders

Evaluation and Conservative Management of Sleep Apnea

Innovation in the Management of Sleep Apnea: From Surgery to Upper Airway Stimulation

Parasomnias Including REM Sleep Behavior Disorder

Evaluation of Hypersomnia

Management of Hypersomnia

Sleep in Neurodegenerative Disorders

Restless Legs Syndrome

17th Annual Sleep Medicine Virtual CME Course Schedule

Lecture Agenda & Faculty

07:45 am - 08:00 am (PST)

08:00 am - 09:00 am (PST)

09:00 am - 10:00 am (PST)

10:00 am - 11:00 am (PST)

11:00 am - 12:00 pm (PST)

12:00 pm - 01:00 pm (PST)

Lunch Break & Product Theater

01:00 pm - 02:00 pm (PST)

02:00 pm - 03:00 pm (PST)

03:00 pm - 04:00 pm (PST)

04:00 pm - 05:00 pm (PST)

05:00 pm - 06:00 pm (PST)

06:00 pm - 06:10 pm (PST)

Live Virtual Conference

The virtual conference will be live-streamed. Course registrants will be provided on-demand access to a recording of the conference for one month immediately following the conference.

Accreditation Statement

The American Academy of Sleep Medicine (AASM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AASM designates this live activity for AMA PRA Category 1 Credits™
17th Annual Sleep Medicine Virtual Course - Maximum of 9.0
AASM Continuing Education Credits (CECs) for sleep technologists are offered for this live activity. AASM designates this live activity for AASM CECs:
17th Annual Sleep Medicine Virtual Course - Maximum of 9.0
The AASM will issue all other non-physicians a letter of attendance for activities designated for AMA PRA Category 1 Credits™.
Physicians and all other participants should claim only the credit commensurate with the extent of their participation in the activity

Letter of Attendance

Physician Assistant (PA) Credit

Nurse Practitioner (NP) Credit

Planner Disclosures:

The following planners have no relevant financial relationships with any ineligible companies to disclose:

Alon Y. Avidan MD, MPH disclosed financial relationships with Avadel Pharmaceuticals (USA), Inc. (consultant), Harmony Biosciences (consultant), Idorsia (consultant), Merck (consultant and Data And Safety Monitoring), and Takeda (consultant).

The relevant financial relationships have been mitigated.

This educational initiative is supported by independent medical education grants from:

Alkermes Inc.

Avadel CNS Pharmaceuticals, LLC

Inspire Medical Systems, Inc.

Jazz Pharmaceuticals Inc

Takeda Pharmaceuticals U.S.A., Inc.